
ACTRIMS Summit
ACTRIMS is committed to fostering the careers of young investigators and clinicians by offering mentorship and educational opportunities to drive growth and innovation in the field of MS.
For the first time, the annual Neurology Resident Summit in Multiple Sclerosis and Young Scientist Summit in Clinical Neuroimmunology will be held in-conjunction with the ACTRIMS Forum 2026 creating the ACTRIMS Summit 2026.
Format
ACTRIMS SUMMIT
February 3-4, 2025 | San Diego, California
Monday, February 2, 2026 | Arrivals |
---|---|
Tuesday, February 3, 2026 | Joint programming applicable to both tracks |
Wednesday, February 4, 2026 | Targeted breakout sessions specific to each track |
Thursday, February 5 - 7, 2026 | ACTRIMS Forum 2026 |
Accepted participants will participate in the Summit programming on February 3 & 4th, receive complimentary registration to the ACTRIMS Forum 2026, a hotel room for the duration of the Summit and Forum, and roundtrip economy airfare to the meeting location.
Applications Open: August 1, 2025
Applications Close: October 15, 2025
Notifications Sent: November 1, 2025
Resident Summit Track
The goal of the ACTRIMS Neurology Resident Summit is to primarily educate fourth-year medical students, PGY-2 and/or PGY-3 residents about:
State of the art MS therapeutics and research
Opportunities for training in fellowship programs
The spectrum of careers that are attainable in MS research and clinical practice
The Resident Summit, chaired by Dr. Benjamin Segal, provides a historical perspective on the management of MS, an overview of future directions in MS therapeutics, expert panel discussions, and networking opportunities to discuss careers in clinical and investigate neuroimmunology.
Application includes:
Applicant details,
Current CV, and
Letter of nomination from residency director or mentor.
APPLICATION OPENS AUGUST 1
Young Scientist Summit Track
A core value of ACTRIMS is to mentor and support the careers of students, neurology residents, postdoctoral fellows, and junior faculty interested in clinical neuroimmunology and/or clinical MS, including:
MS diagnostic criteria,
Clinical subtypes,
Epidemiology,
Human neuropathology,
Animal models: strengths and weaknesses,
The current therapeutic landscape in MS, and
Mechanisms of action of disease modifying therapies.
The long-term goal is to bridge the gap between bench and bedside research, fostering collaboration between PhD investigators and their physician colleagues.
Applicants may be graduate students (Masters, PhD, MD/PhD), medical students, research associates, postdoctoral fellows, or junior faculty with a research interest in MS.
As a North American organization, preference is given to applicants from the US and Canada. Acceptance of international applications is decided on a case-by-case basis.
Applications include:
Applicant details,
Current CV, and
An acknowledgment form* signed by applicant's mentor/supervisor.
*The fillable form to be included with the application can be found here.
APPLICATION OPENS AUGUST 1